These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 15564841)
1. Familial non-medullary thyroid cancer: a matched-case control study. Maxwell EL; Hall FT; Freeman JL Laryngoscope; 2004 Dec; 114(12):2182-6. PubMed ID: 15564841 [TBL] [Abstract][Full Text] [Related]
2. Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. Uchino S; Noguchi S; Kawamoto H; Yamashita H; Watanabe S; Yamashita H; Shuto S World J Surg; 2002 Aug; 26(8):897-902. PubMed ID: 11965446 [TBL] [Abstract][Full Text] [Related]
3. Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series. Alsanea O; Wada N; Ain K; Wong M; Taylor K; Ituarte PH; Treseler PA; Weier HU; Freimer N; Siperstein AE; Duh QY; Takami H; Clark OH Surgery; 2000 Dec; 128(6):1043-50;discussion 1050-1. PubMed ID: 11114641 [TBL] [Abstract][Full Text] [Related]
6. Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Capezzone M; Marchisotta S; Cantara S; Busonero G; Brilli L; Pazaitou-Panayiotou K; Carli AF; Caruso G; Toti P; Capitani S; Pammolli A; Pacini F Endocr Relat Cancer; 2008 Dec; 15(4):1075-81. PubMed ID: 18832444 [TBL] [Abstract][Full Text] [Related]
7. Well-differentiated thyroid carcinoma: factors predicting recurrence and survival. Lim LH; Soo KC; Chong YK; Gao F; Hong GS; Lim TH Singapore Med J; 2002 Sep; 43(9):457-62. PubMed ID: 12568423 [TBL] [Abstract][Full Text] [Related]
8. Implications of prognostic factors and risk groups in the management of differentiated thyroid cancer. Shaha AR Laryngoscope; 2004 Mar; 114(3):393-402. PubMed ID: 15091208 [TBL] [Abstract][Full Text] [Related]
9. A population-based analysis of survival factors in differentiated and medullary thyroid carcinoma. Bhattacharyya N Otolaryngol Head Neck Surg; 2003 Jan; 128(1):115-23. PubMed ID: 12574769 [TBL] [Abstract][Full Text] [Related]
11. A model for predicting outcomes in patients with differentiated thyroid cancer and model performance in comparison with other classification systems. Yildirim E J Am Coll Surg; 2005 Mar; 200(3):378-92. PubMed ID: 15737848 [TBL] [Abstract][Full Text] [Related]
12. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Hiltzik D; Carlson DL; Tuttle RM; Chuai S; Ishill N; Shaha A; Shah JP; Singh B; Ghossein RA Cancer; 2006 Mar; 106(6):1286-95. PubMed ID: 16470605 [TBL] [Abstract][Full Text] [Related]
13. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Volante M; Landolfi S; Chiusa L; Palestini N; Motta M; Codegone A; Torchio B; Papotti MG Cancer; 2004 Mar; 100(5):950-7. PubMed ID: 14983490 [TBL] [Abstract][Full Text] [Related]
14. Familial history of non-medullary thyroid cancer is an independent prognostic factor for tumor recurrence in younger patients with conventional papillary thyroid carcinoma. Lee YM; Yoon JH; Yi O; Sung TY; Chung KW; Kim WB; Hong SJ J Surg Oncol; 2014 Feb; 109(2):168-73. PubMed ID: 24132694 [TBL] [Abstract][Full Text] [Related]
15. Familial nonmedullary thyroid carcinoma-clinical relevance and prognosis. A European multicenter study. ESES Vienna presentation. Hillenbrand A; Varhaug JE; Brauckhoff M; Pandev R; Haufe S; Dotzenrath C; Köberle R; Hoffmann R; Klein G; Kadmon M; Negele T; Hagieva T; Henne-Bruns D; Luster M; Weber T Langenbecks Arch Surg; 2010 Sep; 395(7):851-8. PubMed ID: 20683623 [TBL] [Abstract][Full Text] [Related]
16. Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging. Lin JD; Chao TC; Chen ST; Huang YY; Liou MJ; Hsueh C Surg Oncol; 2007 Aug; 16(2):107-13. PubMed ID: 17600699 [TBL] [Abstract][Full Text] [Related]
17. Differentiated thyroid cancer and outcome in iodine deficiency. Gyory F; Balazs G; Nagy EV; Juhasz F; Mezosi E; Szakall S; Math J; Lukacs G Eur J Surg Oncol; 2004 Apr; 30(3):325-31. PubMed ID: 15028317 [TBL] [Abstract][Full Text] [Related]
18. Adjuvant external-beam radiotherapy in patients with high-risk well-differentiated thyroid cancer. Chen PV; Osborne R; Ahn E; Avitia S; Juillard G Ear Nose Throat J; 2009 Jul; 88(7):E01. PubMed ID: 19623515 [TBL] [Abstract][Full Text] [Related]
19. Does Hurthle cell lesion/neoplasm predict malignancy more than follicular lesion/neoplasm on thyroid fine-needle aspiration? Pu RT; Yang J; Wasserman PG; Bhuiya T; Griffith KA; Michael CW Diagn Cytopathol; 2006 May; 34(5):330-4. PubMed ID: 16604553 [TBL] [Abstract][Full Text] [Related]
20. Biological behavior and prognosis of familial papillary thyroid carcinoma. Ito Y; Kakudo K; Hirokawa M; Fukushima M; Yabuta T; Tomoda C; Inoue H; Kihara M; Higashiyama T; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Miyauchi A Surgery; 2009 Jan; 145(1):100-5. PubMed ID: 19081481 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]